Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comparative Study
. 2014 Feb;145(2):346-353.
doi: 10.1378/chest.13-1176.

The impact of coexisting COPD on survival of patients with early-stage non-small cell lung cancer undergoing surgical resection

Rihong Zhai  1 , Xiaojin Yu  1 , Andrea Shafer  2 , John C Wain  3 , David C Christiani  4
Affiliations
Comparative Study

The impact of coexisting COPD on survival of patients with early-stage non-small cell lung cancer undergoing surgical resection

Rihong Zhai et al. Chest. 2014 Feb.

Abstract

Background: COPD is a recognized risk factor for lung cancer, but studies of coexisting COPD in relation to lung cancer outcomes are limited. We assessed the impact of COPD on overall survival (OS) and progression-free survival (PFS) in patients with early-stage non-small cell lung cancer (NSCLC).

Methods: Patients (N = 902) with early-stage (stage IA-IIB) NSCLC treated with surgical resection were retrospectively analyzed. The association of self-reported, physician-diagnosed COPD with survivals of NSCLC was assessed using the log-rank and Cox regression models, adjusting for age, sex, BMI, smoking, stages, and performance status.

Results: Among this cohort of patients with NSCLC, 330 cases had physician-diagnosed COPD, and 572 did not have COPD. The 5-year OS in patients with COPD (54.4%) was significantly lower (P = .0002) than that in patients without COPD (69.0%). The 5-year PFS rates for patients with COPD and without COPD were 50.1% and 60.6%, respectively (P = .007). Compared with patients without COPD, patients with COPD had increased risk of worse OS (adjusted hazard ratio [HRadj] = 1.41, P = .002) and PFS (HRadj = 1.67, P = .003). The associations between COPD and worse survival outcomes were stronger in men and in squamous cell carcinoma (SCC).

Conclusions: Coexisting COPD is associated with worse survival outcomes in patients with early-stage NSCLC, particularly for men and for SCC.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
Kaplan-Meier curve of overall survival (OS) by COPD. COPD was associated with significantly shorter OS in early stage non-small cell lung cancer (P = .0002, log-rank test).
Figure 2.
Figure 2.
Kaplan-Meier curve of progression-free survival (PFS) by COPD. COPD was associated with significantly shorter PFS in early-stage non-small cell lung cancer (P = .007, log-rank test).
See this image and copyright information in PMC

References

    1. Mannino DM, Buist AS. Global burden of COPD: risk factors, prevalence, and future trends. Lancet. 2007;370(9589):765-773 - PubMed
    1. Buist AS, McBurnie MA, Vollmer WM, et al. ; BOLD Collaborative Research Group International variation in the prevalence of COPD (the BOLD Study): a population-based prevalence study. Lancet. 2007;370(9589):741-750 - PubMed
    1. Decramer M, Janssens W, Miravitlles M. Chronic obstructive pulmonary disease. Lancet. 2012;379(9823):1341-1351 - PMC - PubMed
    1. Rabe KF, Hurd S, Anzueto A, et al. ; Global Initiative for Chronic Obstructive Lung Disease Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med. 2007;176(6):532-555 - PubMed
    1. Raviv S, Hawkins KA, DeCamp MM, Jr, Kalhan R. Lung cancer in chronic obstructive pulmonary disease: enhancing surgical options and outcomes. Am J Respir Crit Care Med. 2011;183(9):1138-1146 - PubMed

Publication types

MeSH terms